REBN Fundamental Analysis - REBORN COFFEE INC

Name: REBORN COFFEE INC (REBN) Stock
Brand: REBORN COFFEE INC
Rating: 3.5 (3 reviews)

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to REBN. REBN was compared to 39 industry peers in the Consumer Staples Distribution & Retail industry. Both the profitability and financial health of REBN have multiple concerns. REBN is not valued too expensively and it also shows a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

REBN had negative earnings in the past year.

In the past year REBN has reported a negative cash flow from operations.

In the past 5 years REBN always reported negative net income.

In the past 5 years REBN always reported negative operating cash flow.

1.2 Ratios

The Return On Assets of REBN (-157.24%) is worse than 97.44% of its industry peers.

		Industry Rank	Sector Rank
ROA	-157.24%
ROE	N/A
ROIC	N/A

ROA(3y)-49.38%

ROA(5y)-56.98%

ROE(3y)-173.87%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 57.89%, REBN belongs to the top of the industry, outperforming 94.87% of the companies in the same industry.

In the last couple of years the Gross Margin of REBN has remained more or less at the same level.

REBN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	57.89%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.17%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

REBN does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for REBN has been increased compared to 1 year ago.

Compared to 1 year ago, REBN has an improved debt to assets ratio.

2.2 Solvency

REBN has an Altman-Z score of -10.12. This is a bad value and indicates that REBN is not financially healthy and even has some risk of bankruptcy.

The Altman-Z score of REBN (-10.12) is worse than 97.44% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-10.12

ROIC/WACCN/A

WACC9.1%

2.3 Liquidity

REBN has a Current Ratio of 0.14. This is a bad value and indicates that REBN is not financially healthy enough and could expect problems in meeting its short term obligations.

With a Current ratio value of 0.14, REBN is not doing good in the industry: 94.87% of the companies in the same industry are doing better.

A Quick Ratio of 0.11 indicates that REBN may have some problems paying its short term obligations.

REBN has a Quick ratio of 0.11. This is amonst the worse of the industry: REBN underperforms 94.87% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.14
Quick Ratio	0.11

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

REBN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.78%.

The Revenue has been growing slightly by 5.83% in the past year.

Measured over the past years, REBN shows a very strong growth in Revenue. The Revenue has been growing by 37.51% on average per year.

EPS 1Y (TTM)-6.78%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-140.11%

Revenue 1Y (TTM)5.83%

Revenue growth 3Y37.51%

Revenue growth 5YN/A

Sales Q2Q%33.64%

3.2 Future

REBN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 126.37% yearly.

Based on estimates for the next years, REBN will show a very strong growth in Revenue. The Revenue will grow by 52.11% on average per year.

EPS Next Y260%

EPS Next 2Y164.58%

EPS Next 3Y126.37%

EPS Next 5YN/A

Revenue Next Year64.55%

Revenue Next 2Y57.31%

Revenue Next 3Y52.11%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

REBN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

The Price/Forward Earnings ratio is 6.31, which indicates a rather cheap valuation of REBN.

89.74% of the companies in the same industry are more expensive than REBN, based on the Price/Forward Earnings ratio.

When comparing the Price/Forward Earnings ratio of REBN to the average of the S&P500 Index (31.86), we can say REBN is valued rather cheaply.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	6.31

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

REBN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

REBN's earnings are expected to grow with 126.37% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y164.58%

EPS Next 3Y126.37%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for REBN!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

REBORN COFFEE INC

NASDAQ:REBN (11/6/2025, 8:09:20 PM)

Premarket: 1.61 0 (0%)

1.61

-0.15 (-8.52%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupConsumer Staples Distribution & Retail

GICS IndustryConsumer Staples Distribution & Retail

Earnings (Last)11-14 2022-11-14/amc

Earnings (Next)N/A N/A

Inst Owners11.11%

Inst Owner Change0%

Ins Owners34.55%

Ins Owner Change0%

Market Cap9.61M

Revenue(TTM)6.57M

Net Income(TTM)-10.03M

Analysts82.86

Price TargetN/A

Short Float %1.43%

Short Ratio0.77

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	6.31
P/S	1.46
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-2.27

EYN/A

EPS(NY)0.26

Fwd EY15.84%

FCF(TTM)-0.72

FCFYN/A

OCF(TTM)-0.62

OCFYN/A

SpS1.1

BVpS-0.32

TBVpS-0.32

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-157.24%
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	57.89%
FCFM	N/A

ROA(3y)-49.38%

ROA(5y)-56.98%

ROE(3y)-173.87%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.17%

GM growth 5YN/A

F-Score3

Asset Turnover1.03

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	152.6%
Cap/Sales	8.43%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.14
Quick Ratio	0.11
Altman-Z	-10.12

F-Score3

WACC9.1%

ROIC/WACCN/A

Cap/Depr(3y)332.07%

Cap/Depr(5y)258.1%

Cap/Sales(3y)18.95%

Cap/Sales(5y)17.35%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-6.78%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-140.11%

EPS Next Y260%

EPS Next 2Y164.58%

EPS Next 3Y126.37%

EPS Next 5YN/A

Revenue 1Y (TTM)5.83%

Revenue growth 3Y37.51%

Revenue growth 5YN/A

Sales Q2Q%33.64%

Revenue Next Year64.55%

Revenue Next 2Y57.31%

Revenue Next 3Y52.11%

Revenue Next 5YN/A

EBIT growth 1Y-117%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year684.52%

EBIT Next 3Y187.41%

EBIT Next 5YN/A

FCF growth 1Y53.99%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y14.85%

OCF growth 3YN/A

OCF growth 5YN/A

REBORN COFFEE INC / REBN FAQ

Can you provide the ChartMill fundamental rating for REBORN COFFEE INC?

ChartMill assigns a fundamental rating of 2 / 10 to REBN.

What is the valuation status for REBN stock?

ChartMill assigns a valuation rating of 4 / 10 to REBORN COFFEE INC (REBN). This can be considered as Fairly Valued.

What is the profitability of REBN stock?

REBORN COFFEE INC (REBN) has a profitability rating of 1 / 10.

How financially healthy is REBORN COFFEE INC?

The financial health rating of REBORN COFFEE INC (REBN) is 0 / 10.

REBORN COFFEE INC (REBN) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

REBORN COFFEE INC / REBN FAQ

Can you provide the ChartMill fundamental rating for REBORN COFFEE INC?

What is the valuation status for REBN stock?

What is the profitability of REBN stock?

How financially healthy is REBORN COFFEE INC?